Zepbound is a newer option with less clinical data, but semaglutide GLP-1 remains the most proven and effective for weight management
If you are ready to see whether treatment is a fit, you can complete the free assessment quiz and take the next step
Current Availability and Prescribing Status in the UK Retatrutide is not licensed in the UK and cannot be legally prescribed outside of a registered clinical trial
There is also some risk for unmeasured confounding, and factors like bias because of unmeasured variables, dosing differences, using brand as a proxy for target dose, and missing information could have affected the results
Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database
This is a second-generation product